| Record ID | marc_records_scriblio_net/part19.dat:54122367:1186 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part19.dat:54122367:1186?format=raw |
LEADER: 01186nam 2200325 a 4500
001 86601415
003 DLC
005 19990716000000.0
008 900814s1986 mdua b f000 0 eng c
010 $a 86601415
020 $c$6.50
040 $aDGPO/DLC$cDLC
043 $an-us---
050 00 $aRM666.P49$bP48 1986
082 00 $a616.86/34$220
086 0 $aHE 20.8216:64
245 00 $aPhencyclidine :$ban update /$ceditor, Doris H. Clouet.
260 $aRockville, Md. :$bDept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse ;$a[Washington, D.C. :$bSupt. of Docs., U.S. G.P.O., distributor],$c1986.
300 $axii, 266 p. :$bill. ;$c23 cm.
440 0 $aNIDA research monograph ;$v64
440 0 $aDHHS publication ;$vno. (ADM) 86-1443
504 $aIncludes bibliographies.
500 $aS/N 017-024-01281-5.
500 $aItem 831-C-8.
650 0 $aPhencyclidine$xPhysiological effect.
650 0 $aPhencyclidine abuse$zUnited States.
650 2 $aPhencyclidine.
650 2 $aPhencyclidine abuse.
700 1 $aClouet, Doris H.
710 2 $aNational Institute on Drug Abuse.